Abstract The attempt is made to produce recombinant factor VIII but the first step in producing such product is production and purification of rabbit's polyclonal antibody against factor VIII. The second and third steps involve monoclonal antibody and recombinant factor VIII production. Factor VIII is one of the most important coagulating factor where its deficiency leads to diseases like hemophilia type A or classic. It is an inherited disease. Previously, it was obtained through fractionation of blood plasma of blood donors. After processing, factor VIII could be used to manage such patients. Due to transfer of viral disease like hepatitis and HIV through factor VIII obtained by fractionation, high cost of production, insufficiency of the donors and the process of virus removal, thus production of factor VIII through recombinant technology can be useful and helpful. The reaction between antibody and antigen is one the most specific reaction; therefore, such reaction can be employed to identify factor VIII. Thereby, rabbits were injected several times with adjuvant-linked antigen to produce antibody. The antibody was separated from the blood sample, purified and used to identify factor VIII in the research.
Introduction
Nowadays, purified antibodies are playing major role in the treatment and diagnosis of biological molecules. With regard to the advances in biotechnology and production of recombinant drugs, they are used to separate and identify manufactured products. Hemophilia is one of the inherited hemorrhagic diseases. Safety and the life of hemophilia patients are dependent on the preparation of safe factor VIII [1] . Previously, treated hemophilia patients with FVIII derived from blood plasma were contaminated with hepatitis and HIV viruses [2] . The aim of production and purification of antibody is to control quality of the produced recombinant factor VIII in order to minimize the side effects of plasma derived factor VIII and on the other hand, to prevent the payment of foreign currency to buy such drugs. The molecule of factor VIII (hFVIII) is secretory glycoprotein with the molecular weight of 330 KDa containing 2332 amino acids which is comprised of three similar domains A, of 2 similar domains C and 1 unit domain B. FVIII is arranged as A1-A2-B-A3-C1-C2 domains [3, 4] . The protein with Von Will Brant factor in the form of complex is circulated in blood to be protected and stabilized [5, 6] .
The carbohydrate content of FVIII obtained from plasma is 1% sialic acid, 2.8% hexoseamin and 1-2% hexoses (mannose, galactose and focuses) [6] . It was also analyzed to contain a few molecules of non-polar lipid (include less than 5% protein, this lipid is composed of cholesterol, fatty acid and may contain triglyceride) and no phospholipids. Domain B is not needed for clotting activity of factor VIII [7] . But recent studies on its role in protecting the active form of factor VIII from the inactive proteolytic form are described [8] . Breakage of high chain length (HCL) containing A1-A 2 and domain B, low chain (LCH) A3-C 1 , domain C 2 are formed [2, 9] . Purification of factor VIII gene created a new chance of treatment in 1984 [10, 11] . Through recombinant technology, recombinant factor VIII (rfVIII) which is a safe molecule and free of viruses can be produced [12] [13] [14] . Although, rFVIII is a biologic, and obtained from CHO culture but there is a danger of transferring infectious agents [15] . From the point of viruses transfer, about 25% of first concentrated generation of rFVIII, is positive (due to use of human/calf serum albumin) [16] , on the other hand, the second generation of rFVIII product includes two products, one with full length domain (FL-rFVIII) and the other rFVIII without (BDD-rFVIII) by replacing serum with sucrose which may delete the transfer of viral agents, is produced [16] . In recent years, advancement and safety and therapeutic use of factor VIII have been increased [17] .
Materials and Methods
Today, polyclonal antibodies are produced against specific antigens and then utilized. Antibodies are reagents widely employed in biological fields to test proteins, carbohydrates, lipids and nucleic acids. In addition, synthetic and non synthetic antigens are considerably produced by biochemical, biosynthetic and recombinant techniques to cause specific immune responses. Most of such new antigens are small molecules and weak immunogens so they need to be adsorbed onto adjuvant. In this research, first a vial of factor VIII by the name of ''Antihemophilic factor (human) 570 IU (Talecris)'' was taken to weigh out, the powder of factor VIII was added to an adjuvant namely Aluminum hydroxide with the composition of Al(OH) 3 0.3 mM, NaCl 0.4 mM, Na 2 HPO 4 0.135 mM, NaH 2-PO 4 ÁH 2 O 0.135 mM, the volume of the vial was made to 20 ml with such adjuvant solution. They were divided into 500 ll in the tubes equally. The empty vial was dried, weighed in order to obtain the weight of factor VIII. The weight of factor VIII was also determined spectrophotometrically at k 280 nm [12] and the data obtained was compared to that of Bradford method. Four male Newzeland rabbits were selected, weighed (Italian Macchi balance), and blood was taken from the ears before inoculation of antigen. On 1, 5, 14 days, 4000 lg/0.5 ml of factor VIII antigen was injected into 3 parts of the rabbit's body. Before each injection, they were weighed, and their body temperature was controlled. The blood was taken from the rabbits' ears. Blood samples were kept at refrigerator for 2 h for coagulation. The coagulated blood was separated from the serum by centrifugation at 5000 rpm for 5 min. The serum was kept in Epprndrof tubes and stored at -20°C. The produced antibody was qualitatively and quantitatively evaluated by employing techniques like immunodiffusion, hemagglutination, immunoelectrophoresis. SDS-PAGE, western blot, dot blot and ELISA (19, 20, and 21) .
Immunodiffusion
Two wells were made on agarose gel; antigen and antibody were added to each well. It was kept at refrigerator temperature in a moist chamber for 24 h. It was stained with Coomassie blue. The presence of stained zone indicates antigen-antibody reaction [18, 19] (Fig. 1 ).
Single Radial Immunodiffusion (SRID)
The amount of antibody was determined by single radial immunodiffusion method in a Petri plate (10 cm in diameter). Antibody was diluted as 1/10, 1/100, 1/1000, 1/10000 and 1/100000. The plate was kept at refrigerated temperature in a moist chamber for 24 h. The corona was formed at 1/1000 dilution, therefore the titer of antibody is between 1/1000 and 1/10000, due to high titer of passive hemagglutination [20] (Fig. 2 ).
Staining
Solutions for staining contains: 0.25 g Coomassie blue, 10 ml acetic acid and 50 ml methanol. After mixing, final volume was made to 100 ml with distilled water. The gel was kept in staining solution for 10 min. The excess of stain was removed by distaining solution (methanol 50 ml, acetic acid 50 ml mixed well, the final volume was made to 400 ml with distilled water) for 2 h (19, 20, and 21).
Heamagglutination
It is based on the reaction between antibody and antigen. Here, passive heamagglutination was used. In this test, soluble antigen is sensitized by reagents like, tannic acid, Solution A and B were mixed at the ratio of 2:5 to obtain pH 7.2. The equal volume of C was added to obtain buffer no. 1. They were also mixed at the ratio of 5:2 to obtain pH 6.4. The equal volume of C was added to obtain buffer no. 2. To 15 ml RBC in Alsvers solution, 30 ml of buffer no. 1 was added, mixed and centrifuged for 7-10 min at 800 rpm. This procedure was repeated till to get clear supernatant and to obtain washed RBCs. By using buffer no. 1, 50 ml of 1:1000 tannic acid solutions was prepared and 10 ml of this solution along with 10 ml of buffer no. 1 were added to washed RBCs; thereby the concentration of tannic acid solution became 1:20000. It was kept at room temperature for 30 min, and then it was washed twice with buffer no. 1 and once with buffer no. 2. The RBCs sensitized with tannic acid were diluted to 2.5% RBCs with buffer no. 2. This was mixed with equal volume of antigens in buffer no. 2 and left at room temperature for 1 h. It was washed with buffers no. 1 and 2 (twice and once respectively) and centrifuged as before. The antibody in 96 wells plate was diluted serially with buffer no. 1 and to each well 100 ll RBCs (2.5%) was added. Positive and negative controls were designed on two rows of the wells. The prepared wells were kept at refrigerator for 24 h and the titer of the antibody was determined [13, 19, 21] (Fig. 3) .
Immunoelectrophoresis
On agarose gel prepared on glass slid, two wells of 3 mm on each side were made by Pasteur pipette and a groove in the middle by Gellman LKB. The slide was kept in IEF tank [22] .
Tank buffer solution was made of: Tris-barbital buffer 4X, diethyl barbitoric acid 22.4 g, tris base 44.3 g and calcium lactate 0.53 g and volume was made to 1000 ml with distilled water and adjustment of pH was not needed. It was diluted at the ratio of 1:4 before use. Tank buffer was added from two sides of the chamber reaching under the gel where the gel was in the middle of the chamber. Then Whatman paper (12.5 9 3 cm) was used as bridge between gel and buffer to connect them together. 5 ll of antigen was added to a well on top right side and it was marked as anode. The immunoelectrophoresis was carried out at the current of 6 mA or 120 V for 45 min. Then 15 ll antibody in 50 ll tris-barbital buffer was added to the stria, it was incubated in moist chamber at refrigerator temperature overnight and stained by Coomassie blue. Deviation of antigen toward antibody could be distinguished (Fig. 4) . SDS-PAGE: It is a qualitative and quantitative method. Different concentrations of antigen ranged from 5 to 30 ll (at the interval of 5 ll) were used. The best band was obtained with 5 ll antigen concentration after staining [23] (Fig. 5) .
Western Blot
Western blot or immune blot is employed to detect the target protein [9] and it is meant to check the target protein in the sample. It is a sensitive method and is designed to track and detect macromolecules. Detection is based on the specific reaction between antibody and antigen. The protein band obtained by SDS-PAGE is transferred to nitrocellulose or polyvinyldifloride membrane which is then probed by its corresponding antigen/antibody.
Materials, Reagents and Equipments
Preparation of running buffer or tank buffer: glycine 28 g, tris base 6 g, SDS 2 g were dissolved in 1.8 l of distilled water, pH was adjusted to 8.3 and the volume was made to 2 l.
Tris saline tween 20 buffer was prepared by dissolving NaCl 8.8 g, KCl 0.2 g, tris base 3 g and 0.5 ml tween 20 in 800 ml distilled water. The pH was adjusted to 4.7, the volume was made to 1000 ml and then sterilized (Fig. 6) .
Purification of Antibody Produced in Rabbits
To purify antibody, different techniques such as Ionexchange, affinity chromatographies, ammonium sulfate precipitation of IgG or caprilic acid methods have been mentioned in the literatures [21] [22] [23] .
Purification of IgG by Caprilic Acid and Ammonium Sulfate
In this method, 2 ml serum was added to 8 ml acetate buffer (sodium acetate 0.147 g, acetic acid 295 ll, D/W 100 ml). It was then mixed, pH was adjusted to 4.5 and then caprilic acid 250 ll was introduced drop wise under stirring condition. It was centrifuged at room temperature, 10000g for 30 min. The supernatant was filtered and equilibrated at 4°C then ammonium sulfate was added, stirred and then kept at 4°C for 30 min. The precipitated IgG was separated by centrifugation at 10000g and 4°C for 15 min. The precipitate was dissolved in PBS at the ratio of 1:2 and dialyzed over night. SDS-PAGE was performed to check the purity of the product with the reference literature (Fig. 7) .
Results
The aim of this research is to produce recombinant factor VIII and to control the quality of such product; the production and purification of factor VIII polyclonal antibody should be carried out. Our previous experience involves production of morphine antibody [24] , extended to production of factor VIII polyclonal antibody, application of polyclonal antibody in production of factor VIII, measurement of produced antibody in patients suffering from hemophilia, various methods to determine antibody, antigen determination, determination of concentration, serology, immunodiffusion, electrophoresis methods, different hemagglutination like passive hemagglutination for serum titer determination, SDS-PAGE to check the purity of purified antibody, dot blot, western blot, antibody purification methods, antibody quality control, protein determination, rabbit immunization, blood sampling of rabbits, serum separation, methods of antibody titer determination, methods of dialysis are the techniques set up and the infra structures available in the department make us capable to produce recombinant factor VIII. We considered safety, quality control, stability, production processes by following WHO and NRA of I. R. Iran guide lines.
Discussion
Factor VIII is one of the most important coagulation factor where its deficiency causes hemophilia A disease. Hemophilia A, one of the most severe bleeding disorders, results from an inherited deficiency of factor VIII (FVIII) function. Factor VIII can be produced either by Cryo or recombinant methods. It is used intravenously. Due to presence of impurities in factor VIII, it is expressed in IU rather than protein concentration. Therefore, in this research, the weight was expressed in terms of protein concentration which was determined spectrophotometrically. Due to low absorbance (purified factor VIII) obtained by many investigators at k 280 nm, this could be due to low aromatic amino acid content of factor VIII [25] , thereby protein was also measured by Bradford method. The amount of factor VIII in patients is determined by PTT method, in these patients the amount of PT is usually normal and PTT will be high hence, by adding plasma of normal person, the amount of PTT will be normal. Antibody against factor VIII can be observed in patients injected with factor VIII several times. Antibody against factor VIII in old people is seen, of course, in rare cases [19] . ) showing factor VIII is active. When antibody produced in rabbits against factor VIII is in contact with antigen, a single precipitated band is observed on the gel upon immunoelectrophoresis. The titer of antibody was determined by hemagglutination and radial immunodiffusion method indicating the potency of antibody, it can distinguish antigen even at low titer. In various papers, antibodies are purified by different procedures but here, we have employed caprilic acid to purify antibody. The bands observed on SDS-PAGE correspond to bands observed in reference papers [21, 23] . In this way, selected method is a proper method to purify antibody. In this article attempts are made to produce antibody in rabbits through proper methods of antibody production and quality control.
